
BAKX Therapeutics
closedWe create targeted cancer therapies through unique insights into the conformationally dynamic protein drivers of the mitochondrial apoptosis pathway combined with structure-based drug design and computational simulations.
Employees
Enterprise value
$100—150m
Authorizing premium user...